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Hypothesis: Our central hypothesis is that inhibition of Schwann cell de-differentiation, 31 in the post-injury setting, will reduce synkinesis and improve facial muscle function 32 Background: No therapies exist to improve the accuracy of facial nerve regeneration. 33 Following peripheral nerve injury, adult reactive Schwann cells de-differentiate and 34 express glial fibrillary acidic protein (GFAP); suggesting that reactive Schwann cells 35 impact axonal regeneration precision. 36 37 Methods: Transgenic GFAP-thymidine kinase (TK) mouse model was employed, 38 allowing selective downregulation of reactive GFAP expressing Schwann cells on 39 exposure of 7 day osmotic pump delivery of ganciclovir. Adult female transgenic GFAP- 40 TK mice had right facial nerve transected and then immediately repaired with tissue 41 glue, they then either were treated with saline or ganciclovir (GCV). At 6 weeks post- 42 injury, mice were exposed to random air puffs events while high speed videography 43 recorded whisker and eye movement. MatLab code video processing with publicly 44 available BIOTACT algorithm automatically tracked whiskers. 45 Results: Whisker velocity was calculated using binning statistical analysis. Saline 46 treated animals confirmed our model's ability to detect aberrant movement such that 47 intact (left) facial nerves caused whisker protraction, while repaired (right) facial nerves 48 had retraction. Administration of GCV increased whisker retraction compared to saline. 49 GCV did not impact intact animal whisker movement compared to repaired whiskers. Facial nerve injury severely limits facial function typically resulting in weak facial 72 expressions and abnormal simultaneous mouth movement and eye closure or 73 synkinesis 1 . This aberrancy can occur either within the nerve fascicles itself or at the 74 facial muscle motor end-plates, resulting in the physiologic finding of synkinesis 2 . 75 Despite advances in microsurgical techniques, complete nerve transection with primary 76 neurorrhaphy is classically believed to lead incomplete recovery with synkinesis.
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A well-characterized model to study nerve reinnervation is the mouse femoral nerve By applying a Fourier decomposition to the whisker data, we were able to characterize 182 the motion of the whiskers in each phase of motion. In particular, by looking at which 183 frequencies were the most powerful at any given time, we were able to place a 184 statistical constraint on which frames were most relevant for velocity comparison. In 185 order to determine how many frames the initial post-puff phase lasts, we adopted the 186 following procedure: 1) Establish the peak of the frequency distribution (the Power 187 Spectral Density or PSD) before the puff (PSD_i). 2) Calculate the peak of the PSD for 188 increasing numbers of frames following the puff (PSD_f). 3) Calculate the magnitude of 189 the difference between these two numbers. As the number of frames increases, we 190 expect the PSD_f to diverge from PSD_i until some maximum difference, at which point 191 it will start to return to its previous stochastic motion, and the numbers begin to 192 converge. 193 194 When we perform this analysis, we find that this peak occurs at approximately frame 20 195 across all data runs. Fig. 4b shows an example of this analysis for one data run. 196 197 Having done this, we could extract the data from just those frames which immediately 198 followed the puff, and look at their average velocity in order to compare the motion of 199 whiskers from different data runs. To evaluate the post-puff velocity behavior, we evaluate the whisker velocity in the 20 212 frames immediately following the puff. That number was determined by investigating 213 the average number of frames required for the whiskers to return to a pre-puff state. 214 Characterizing the pre-puff motion by looking at the distribution in frequency (known as 215 the power spectral density or PSD), we can compare the post-puff PSD (PSDf) with the 216 pre-puff PSD (PSDi) by making a simple subtraction and taking the average value. As 217 we increase the number of frames since the puff, this difference will grow as the 218 frequencies of the whisker movements experience a randomization period from the puff, 219 until they start to return to their pre-puff distribution. Thus, the difference in PSD pre-220 and post-puff will show a peak. This is demonstrated for one data run in figure 4a. We 221 use this peak as the threshold to perform the velocity analysis, as this is the data which 222 will best capture the whisker behavior immediately after the puff, before it has returned 223 11 11 to its undisturbed (pre-puff) motion. Figure 4b shows the peak for all data runs, showing 224 that the peak occurs at 20.4 ± 3 frames. For simplicity, we take the value to be 20. Defining facial nerve synkinesis is a matter of understanding normal facial nerve 250 function. In the rodent, facial nerve function dictates eye lid and whisker position 5 . 251 Following puff exposure, the intact side responded with eyelid closure and whisker 252 protraction. In the injured side, retraction was seen with eyelid closure representing 253 synkinesis. Suppression of reactive Schwann cells appears to worsen facial nerve 254 recovery, suggesting that they play a key role in regeneration accuracy. 255 Here we capture facial nerve function with minimal modification to animal itself. 256 Additionally, high spatiotemporal videography (ie 500 frames per second) allowed for 257 large amount of data pertaining to simultaneous eyelid and whisker position. Estimation 258 of error in calculation of whisker position was minimal at 500 frames per second 6 . 259 The main weakness of our study is the lack of histologic confirmation of GCV In conclusion, this study develops the first transgenic mouse model to study synkinesis. 266 We demonstrate, the pharmacologic suppression of Schwann negative impact on facial 267 nerve function. The benefit of using a mouse model, is the vast number of genetic 268 mutations that can be targeted for parallel, high through-put post-injury and therapy 269 screening of molecular targets. 
